AEON AMEX
AEON Biopharma, Inc.
1W: -0.1%
1M: -2.8%
3M: -63.9%
YTD: -76.3%
1Y: -67.1%
3Y: -99.9%
$0.28
-0.01 (-3.79%)
Weekly Expected Move ±19.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$12.3M
52W Range0.177-1.45
Volume3,208,022
Avg Volume5,928,578
Beta0.65
Dividend—
Analyst Ratings
Company Info
CEORobert Bancroft
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2023-07-24
Websiteaeonbiopharma.com
5 Park Plaza
Irvine, CA 92614
US
Irvine, CA 92614
US
949-354-6499
About AEON Biopharma, Inc.
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Latest News
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference
HC Wainwright Comments on AEON Biopharma Q3 Earnings
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
AEON Biopharma regains NYSE American listing compliance after $13.6M offering
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LYNCH TIMOTHY P | P-Purchase | 1,150,000 | $0.21 | 2026-08-19 |
| LYNCH TIMOTHY P | 0 | — | 2026-08-19 | |
| LYNCH TIMOTHY P | 3,000,000 | $0.32 | 2026-07-15 | |
| LYNCH TIMOTHY P | 3,000,000 | $0.37 | 2026-07-15 | |
| Thunen Shelley B | A-Award | 222,684 | — | 2026-06-17 |